THRODAHL MARK C (President and CEO) received a stock award from ORTHOPEDIATRICS CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/28/2025ACC: 0001425450-25-000061
DirectorOfficer· President and CEO
Since Feb 2019
+8.40K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.40K
Price / share
—
Trade value
—
% of position
5.3%
5/23/2025
159.48K→167.88K
Total
Net shares
+8.40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/23/2025 | A · Award | +8.40K | — | — | 5.3% | 159.48K | 167.88K |
| Total | +8.40K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned22.50K
Total
22.50K indirect22.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 22.50K | Indirect |
| Total | 22.50K | 22.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported